Important information

A person with a suspected urogenital cancer should be referred to a urologist who is a member of a relevant multidisciplinary team.

All specialists listed on Canrefer are members of a multidisciplinary team.


What is urogenital cancer?

Urogenital cancer is cancer that starts in the cells of the urinary tract which includes the bladder and kidneys. Urogenital cancers of the prostate, testes (testicles) and penis occur in men.

For more information on prostate cancer, see the prostate cancer page.

Graphic of a human body highlighting the urogenital tract.


What tests are needed?

Common tests used to diagnose a urogenital cancer include:

  • physical examination
  • blood tests
  • imaging - ultrasound, CT scan and/or MRI scan
  • biopsy.


What treatment options are there?

Treatment for urogenital cancer may include one or more of the following:

  • surgery
  • chemotherapy
  • targeted therapy
  • radiotherapy.

If treatment is specialised and complex, patients may need to travel to have a part of their treatment. The local health district will have an arrangement in place for this.


How common is urogenital cancer in NSW?

Urogenital cancer was diagnosed in:

  • 2011
    9522 people in NSW
  • 2012
    9745 people in NSW
  • 2013
    9095 people in NSW

Data source: Annual NSW cancer incidence and mortality dataset, 2013 (sourced from the NSW Cancer Registry)